π£ VC round data is live. Check it out!
- Public Comps
- Jushi Holdings
Jushi Holdings Valuation Multiples
Discover revenue and EBITDA valuation multiples for Jushi Holdings and similar public comparables like Ascend Wellness Holdings, Grown Rogue International, Ispire Technology, Cannara Biotech and more.
Jushi Holdings Overview
About Jushi Holdings
Jushi Holdings Inc is a vertically integrated multi-state cannabis and hemp operator engaged in retail, distribution, cultivation, and processing in both medical and adult-use markets. The company operates a diverse portfolio of branded cannabis and hemp-derived assets built upon opportunistic acquisitions, distressed deals, and competitive applications. Its products are offered through brands like Hijinks, The Bank, The Lab, Seche, and Tasteology, among others. The company distributes its products through various retail dispensaries, including Natureβs Remedy, Beyond Hello, and NuLeaf, and also operates an e-commerce platform called The Jushi Shop, offering branded apparel, accessories, and other products of its different brands. All of its revenues are generated within the United States.
Founded
2007
HQ

Employees
1.2K
Website
Financials (LTM)
EV
$370M
Valuation Multiples
Start free trialJushi Holdings Financials
Jushi Holdings reported last 12-month revenue of $267M and EBITDA of $51M.
In the same LTM period, Jushi Holdings generated $118M in gross profit, $51M in EBITDA, and had net loss of ($60M).
Revenue (LTM)
Jushi Holdings P&L
In the most recent fiscal year, Jushi Holdings reported revenue of β and net income of β.
Financial data powered by Morningstar, Inc.
Jushi Holdings Stock Performance
Jushi Holdings has current market cap of $101M, and enterprise value of $370M.
Market Cap Evolution
Jushi Holdings' stock price is $0.50.
Jushi Holdings share price decreased by 2.8% in the last 30 days, and increased by 74.0% in the last year.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $370M | $101M | 0.0% | -2.8% | 3.0% | 74.0% | β |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialJushi Holdings Valuation Multiples
Jushi Holdings trades at 1.4x EV/Revenue multiple, and 7.3x EV/EBITDA.
EV / Revenue (LTM)
Jushi Holdings Financial Valuation Multiples
As of May 20, 2026, Jushi Holdings has market cap of $101M and EV of $370M.
Jushi Holdings has a P/E ratio of (1.7x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Jushi Holdings Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Jushi Holdings Margins & Growth Rates
Jushi Holdings Margins
Jushi Holdings Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Jushi Holdings Operational KPIs
Jushi Holdings' Rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Jushi Holdings' Rule of X is 28% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Jushi Holdings Competitors
Jushi Holdings competitors include Ascend Wellness Holdings, Grown Rogue International, Ispire Technology, Cannara Biotech, Organigram Global, Planet 13, WM Tech, MariMed, iAnthus Capital Holdings and SynBiotic.
Most Jushi Holdings public comparables operate across Cannabis, CannaTech and ViceTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| β | 1.3x | β | 5.7x | |||
| β | β | β | β | |||
| 0.9x | 1.1x | (3.4x) | (34.9x) | |||
| 1.7x | 1.6x | 6.5x | 6.1x | |||
| 0.8x | 0.7x | 11.1x | 9.0x | |||
| β | 1.0x | β | (13.8x) | |||
| β | 0.0x | β | 0.2x | |||
| β | 0.7x | β | 6.6x | |||
This data is available for Pro users. Sign up to see all Jushi Holdings competitors and their valuation data. Start Free Trial | ||||||
Jushi Holdings Funding History
Before going public, Jushi Holdings raised $68M in total equity funding, across 1 round.
Jushi Holdings Funding Rounds
Jushi Holdings M&A Activity
Jushi Holdings has acquired 9 companies to date.
Last acquisition by Jushi Holdings was on March 17th 2022. Jushi Holdings acquired The Apothecarium for $21M (EV/Revenue multiple of ).
Latest Acquisitions by Jushi Holdings
| Description | The Apothecarium is a licensed medical cannabis dispensary in San Francisco's Castro district. It supplies patients with flowers, edibles, topicals, and concentrates in a secure environment accessible by foot, bike, public transit, or car. Patient consultants guide selections based on medical needs, ensuring compliance with California regulations. The dispensary maintains membership-based access and focuses on quality-controlled products from licensed cultivators. | NuLeaf is a Las Vegas-based vertically integrated cannabis operator licensed in Nevada with cultivation, manufacturing, and retail dispensaries. Operating since 2017, it manages 10,000 square feet of grow facilities producing flower, edibles, and extracts sold through five stores in the Las Vegas valley. NuLeaf supplies premium strains to medical and recreational markets, achieving $20 million in annual revenue amid state expansion. | OhiGrow is a licensed medical marijuana cultivator in Ohio among 34 state-approved facilities. It supplies biomass to processing plants for manufactured cannabis products sold into the wholesale market serving Ohio's medical program. | Natureβs Remedy is a Lakeville-based vertically integrated cannabis company in Massachusetts that cultivates flower and manufactures infused products including edibles and topicals. Its dispensaries operate in Millbury and Tyngsboro, while products reach additional marijuana facilities statewide. The company emphasizes medical-grade quality with on-site production facilities supporting a range of strains and formats for recreational and medical consumers. | |
| HQ Country | |||||
| HQ City | San Francisco, CA | Las Vegas, NV | Toledo, OH | Worcester, MA | |
| Deal Date | 17 Mar 2022 | 17 Nov 2021 | 20 Apr 2021 | 19 Apr 2021 | |
| Valuation | $21M | $63M | $5M | $91M | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Jushi Holdings acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Jushi Holdings
| When was Jushi Holdings founded? | Jushi Holdings was founded in 2007. |
| Where is Jushi Holdings headquartered? | Jushi Holdings is headquartered in United States. |
| How many employees does Jushi Holdings have? | As of today, Jushi Holdings has over 1K employees. |
| Who is the CEO of Jushi Holdings? | Jushi Holdings' CEO is James A. Cacioppo. |
| Is Jushi Holdings publicly listed? | Yes, Jushi Holdings is a public company listed on OTC Pink Sheets. |
| What is the stock symbol of Jushi Holdings? | Jushi Holdings trades under JUSHF ticker. |
| Who are competitors of Jushi Holdings? | Jushi Holdings main competitors include Ascend Wellness Holdings, Grown Rogue International, Ispire Technology, Cannara Biotech, Organigram Global, Planet 13, WM Tech, MariMed, iAnthus Capital Holdings, SynBiotic. |
| What is the current market cap of Jushi Holdings? | Jushi Holdings' current market cap is $101M. |
| What is the current revenue of Jushi Holdings? | Jushi Holdings' last 12 months revenue is $267M. |
| What is the current revenue growth of Jushi Holdings? | Jushi Holdings revenue growth (NTM/LTM) is 11%. |
| What is the current EV/Revenue multiple of Jushi Holdings? | Current revenue multiple of Jushi Holdings is 1.4x. |
| Is Jushi Holdings profitable? | Yes, Jushi Holdings is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Jushi Holdings? | Jushi Holdings' last 12 months EBITDA is $51M. |
| What is Jushi Holdings' EBITDA margin? | Jushi Holdings' last 12 months EBITDA margin is 19%. |
| What is the current EV/EBITDA multiple of Jushi Holdings? | Current EBITDA multiple of Jushi Holdings is 7.3x. |
| What is the current FCF of Jushi Holdings? | Jushi Holdings' last 12 months FCF is ($2M). |
| What is Jushi Holdings' FCF margin? | Jushi Holdings' last 12 months FCF margin is (1%). |
| What is the current EV/FCF multiple of Jushi Holdings? | Current FCF multiple of Jushi Holdings is (223.2x). |
| How many companies Jushi Holdings has acquired to date? | As of May 2026, Jushi Holdings has acquired 9 companies. |
| What was the largest acquisition by Jushi Holdings? | $91M acquisition of Nature's Remedy on 19th April 2021 was the largest M&A Jushi Holdings has done to date. |
| What companies Jushi Holdings acquired? | Jushi Holdings acquired Nature's Remedy, Franklin Bioscience β Penn LLC, NuLeaf, Pennsylvania Medical Solutions, Dalitso LLC, The Apothecarium, OhiGrow, Medicinal Excellence in Neurological Disorders, LLC, and Agape Total Healthcare. |
| In how many companies Jushi Holdings has invested to date? | Jushi Holdings hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Jushi Holdings
Lists including Jushi Holdings
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
